Bêtagenex Inc.

betagenex is a canadian preclinical cro specializing in metabolic diseases with a focus on diabetes and pancreatic beta-cell function. we provide scientific expertise and drug discovery services to the pharmaceutical and biotech industries for compound testing and target validation using state-of-the-art in vivo, ex vivo and in vitro approaches. bêtagenex is part of cardiometabolic hub, a consortium of highly specialized cro grouped to meet global cardiometabolic issues. bêtagenex is also a spin-off of the university of montreal hospital research centre (crchum) chaired by pr vincent poitout, pr marc prentki, dr thierry alquier, dr thierry sulpice, also cso of physiogenex, a worldwide leading preclinical cro and rémy burcelin from inserm (france).